RxDoctor Payments Data

Srinivas Guptha Gunturu, MD

Gastroenterology · Albuquerque, NMNPI 1609011287

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,594 of the $3,127 with a category attached, or 83.0%. It is spread thinly across 16 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,165 and has fallen 83.1% since, to $197 in 2025.

$3,127in general payments, 2019–2025

Across 85 payments — averaging $36.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endogastric Solutions, Inc$733
  • AbbVie$676
  • Olympus America Inc.$378
  • Boston Scientific$253
  • Sanofi$175
  • Medtronic$140
  • plus $773 from 10 others

What the payments were for

  • Travel & lodging$53217%
  • Food & beverage$2,59483%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,127 in reported general payments places this provider in the 70th percentile of 81 gastroenterology providers in New Mexico.

See all gastroenterology providers in New Mexico

Medicare billing

Part B allowed, 2024
$96,080
Medicare patients
345
Services billed
1,018

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate39$6,496
Omeprazole100$753
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine14$682
Pantoprazole Sodium52$493
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl29$475
Clarithromycin13$334
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl21$316
Ciprofloxacin Hcl30$287
Ondansetron OdtOndansetron42$251
Metronidazole20$236
Amoxicillin11$57

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →